RNAi screen analysis of viral host genes
Reference | Disease | Gene | SNP ID | SNP | p-value | Virus |
---|---|---|---|---|---|---|
Reference | Disease | Gene | SNP ID | SNP | p-value | Virus |
23251661 | Obesity-related traits | ABLIM1 | 3983 | rs941853 | 6.00E-06 | WNV |
22219177 | Prostate cancer (gene x gene interaction) | ABLIM1 | 3983 | rs10885582 | 4.00E-06 | WNV |
23551011 | Preeclampsia | ADRA1D | 146 | rs1556832 | 9.00E-06 | WNV |
23377640 | Major depressive disorder | ANKRD27 | 84079 | rs17692896 | 7.00E-07 | WNV |
22952603 | Response to amphetamines | ANKRD31 | 256006 | rs4704187 | 6.00E-06 | WNV |
21782286 | Aging (time to event) | ATCAY | 85300 | rs10412199 | 3.00E-06 | WNV |
20038947 | Major depressive disorder (broad) | ATP6V1B2 | 526 | rs1106634 | 7.00E-07 | WNV |
23455636 | Age-related macular degeneration | B3GALTL | 145173 | rs9542236 | 2.00E-08 | WNV |
23382691 | IgG glycosylation | B4GALT1 | 2683 | rs12342831 | 5.00E-08 | WNV |
23263486 | Urate levels | BAZ1B | 9031 | rs1178977 | 1.00E-12 | WNV |
20864672 | Triglycerides | BAZ1B | 9031 | rs1178979 | 2.00E-12 | WNV |
20657596 | Hypertriglyceridemia | BAZ1B | 9031 | rs714052 | 3.00E-06 | WNV |
19060911 | Triglycerides | BAZ1B | 9031 | rs2240466 | 1.00E-12 | WNV |
20802025 | Protein C levels | BAZ1B | 9031 | rs17145713 | 3.00E-08 | WNV |
23251661 | Obesity-related traits | BICC1 | 80114 | rs11006263 | 7.00E-06 | WNV |
23128233 | Inflammatory bowel disease | CRTC3 | 64784 | rs7495132 | 9.00E-11 | WNV |
21130836 | Information processing speed | CRTC3 | 64784 | rs12915189 | 3.00E-06 | WNV |
23049088 | Myopia (pathological) | DHX15 | 1665 | rs6841898 | 3.00E-26 | WNV |
22890011 | Response to fenofibrate | DOCK4 | 9732 | rs10428959 | 1.00E-07 | WNV |
22788528 | C-reactive protein and white blood cell count | DOCK4 | 9732 | rs10255299 | 7.00E-11 | WNV |
23535732 | Prostate cancer | EBF2 | 64641 | rs11135910 | 8.00E-11 | WNV |
20676098 | Prostate cancer | FOXP4 | 116113 | rs1983891 | 8.00E-08 | WNV |
21804548 | Asthma | GAB1 | 2549 | rs3805236 | 7.00E-08 | WNV |
21835309 | Iris characteristics | HERC1 | 8925 | rs11630290 | 1.00E-06 | WNV |
23446634 | Red blood cell traits | ITFG3 | 83986 | rs13335629 | 3.00E-23 | WNV |
23446634 | Red blood cell traits | ITFG3 | 83986 | rs13339636 | 2.00E-34 | WNV |
23696099 | Red blood cell traits | ITFG3 | 83986 | rs9924561 | 5.00E-29 | WNV |
23446634 | Red blood cell traits | ITFG3 | 83986 | rs1122794 | 1.00E-08 | WNV |
19862010 | Mean corpuscular volume | ITFG3 | 83986 | rs7189020 | 2.00E-12 | WNV |
22952603 | Response to amphetamines | KLHL1 | 57626 | rs2325244 | 8.00E-07 | WNV |
22085899 | Bilirubin levels | KLHL1 | 57626 | rs11843309 | 7.00E-06 | WNV |
19734545 | Cognitive performance | KLHL1 | 57626 | rs7984606 | 8.00E-06 | WNV |
23585552 | Rhegmatogenous retinal detachment | LDB2 | 9079 | rs955943 | 5.00E-06 | WNV |
23534349 | QT interval | LDB2 | 9079 | rs1483012 | 7.00E-06 | WNV |
23362303 | Stearic acid (18:0) plasma levels | LPGAT1 | 9926 | rs11119805 | 3.00E-09 | WNV |
23555189 | PCA3 expression level | MSMB | 4477 | rs10993994 | 1.00E-09 | WNV |
23128233 | Inflammatory bowel disease | NDFIP1 | 80762 | rs6863411 | 4.00E-14 | WNV |
21833088 | Multiple sclerosis | NDFIP1 | 80762 | rs1062158 | 2.00E-06 | WNV |
21507922 | Platelet counts | PITPNM2 | 57605 | rs1727307 | 3.00E-06 | WNV |
22387998 | Duodenal ulcer | PSCA | 8000 | rs2294008 | 2.00E-33 | WNV |
24162737 | Alzheimer's disease (late onset) | PTK2B | 2185 | rs28834970 | 7.00E-14 | WNV |
24097068 | HDL cholesterol | RBM5 | 10181 | rs2013208 | 9.00E-12 | WNV |
22174390 | Heart rate variability traits | RBPMS | 11030 | rs2979481 | 4.00E-06 | WNV |
22267201 | Menopause (age at onset) | RNF44 | 22838 | rs890835 | 6.00E-06 | WNV |
23563607 | Waist-hip ratio | RSPO3 | 84870 | rs7745274 | 9.00E-10 | WNV |
21909109 | Metabolite levels | RSPO3 | 84870 | rs6569474 | 1.00E-08 | WNV |
20935629 | Waist-hip ratio | RSPO3 | 84870 | rs9491696 | 1.00E-11 | WNV |
23563607 | Obesity | SH2B1 | 25970 | rs7498665 | 3.00E-13 | WNV |
20935630 | Body mass index | SH2B1 | 25970 | rs7359397 | 2.00E-20 | WNV |
24124411 | Liver enzyme levels (alanine transaminase) | SLC39A11 | 201266 | rs903107 | 6.00E-06 | WNV |
23698163 | Serum selenium levels | SLC39A11 | 201266 | rs891684 | 4.00E-07 | WNV |
23192594 | Body mass index (interaction) | SLC39A11 | 201266 | rs4969049 | 1.00E-06 | WNV |
22589738 | Visceral adipose tissue adjusted for BMI | SLC39A11 | 201266 | rs12943829 | 2.00E-06 | WNV |
19451621 | Amyotrophic lateral sclerosis | SLC39A11 | 201266 | rs8066857 | 8.00E-06 | WNV |
23934736 | Metabolite levels (X-11787) | SLCO5A1 | 81796 | rs10090896 | 2.00E-06 | WNV |
23535033 | Alzheimer's disease (cognitive decline) | SP6 | 80320 | rs4794202 | 8.00E-08 | WNV |
20708005 | Non-alcoholic fatty liver disease histology (lobular) | ST8SIA1 | 6489 | rs2216228 | 4.00E-06 | WNV |
19079261 | Body mass index | STK33 | 65975 | rs10769908 | 1.00E-06 | WNV |
20935630 | Body mass index | STK33 | 65975 | rs4929949 | 3.00E-09 | WNV |
19114657 | Blood pressure | STK39 | 27347 | rs6749447 | 2.00E-07 | WNV |
24163127 | Bladder cancer | TACC3 | 10460 | rs798766 | 7.00E-25 | WNV |
20881960 | Height | TEAD1 | 7003 | rs7926971 | 4.00E-10 | WNV |
23455636 | Age-related macular degeneration | TGFBR1 | 7046 | rs334353 | 3.00E-11 | WNV |
23128233 | Inflammatory bowel disease | TM9SF4 | 9777 | rs6142618 | 6.00E-10 | WNV |
21452313 | Rheumatoid arthritis | TRHDE | 29953 | rs12831974 | 6.00E-06 | WNV |
23449627 | Pubertal anthropometrics | TRPM3 | 80036 | rs10780944 | 8.00E-07 | WNV |
22808956 | Antineutrophil cytoplasmic antibody-associated vasculitis | TSC22D1 | 8848 | rs17065868 | 3.00E-06 | WNV |
23251661 | Obesity-related traits | UBE3A | 7337 | rs8025093 | 4.00E-06 | WNV |
24144296 | Axial length | WDR34 | 89891 | rs12380424 | 6.00E-06 | WNV |
22064162 | Depression and alcohol dependence | WDR7 | 23335 | rs17750015 | 8.00E-06 | WNV |
23449627 | Pubertal anthropometrics | YAP1 | 10413 | rs11225148 | 2.00E-06 | WNV |
22885925 | Polycystic ovary syndrome | YAP1 | 10413 | rs1894116 | 1.00E-22 | WNV |